36,000+
Yearly Patient Encounters
Established in 2026, the University of Colorado Anschutz Division of Transplant Medicine is the nation's first academic division dedicated to transplant medicine within a Department of Medicine. The Division brings together transplant physicians, scientists, educators and trainees across organ systems to transform the care of patients with advanced organ disease and transplantation and to advance research, education and innovation in this rapidly evolving field.
Whether you are a patient, family member, trainee, researcher, referring physician or prospective faculty member, we are delighted you are here. Thank you for visiting our division! We invite you to learn more about our people, programs, and vision for the future of transplant medicine.
Eddie Stenehjem, MD, MSc
Clinical Director & Interim Division Head of Transplant Medicine
It is an extraordinary privilege to lead the nation's first Division of Transplant Medicine within a Department of Medicine. The creation of our division reflects both the remarkable growth of transplant medicine as a distinct discipline and our commitment to reimagining how academic transplant programs are organized to better serve patients, educate future leaders, and advance discovery. At CU Anschutz, transplantation has evolved into a highly integrated enterprise spanning kidney, liver, heart, and lung transplantation and supported by faculty in infectious diseases, endocrinology, psychiatry, and many other specialties. We are bringing together, in one division, exceptional clinicians, scientists, educators, and trainees with a shared mission to improve the lives of patients with end-stage organ disease.
Our main specialties include transplant nephrology, hepatology and transplant hepatology, and lung transplant. We also partner closely with the Advanced Heart Failure Section in the Division of Cardiology and the Division of Infectious Diseases to ensure synergy between all our organ groups across clinical care, education, research and innovation.
36,000+
Yearly Patient Encounters
500
Avg Yearly Transplants
90
Living Donor Transplants in FY26